Daryl Faulkner

Daryl J. Faulkner served as Director of Venaxis, Inc. as of September 30, 2016. He was appointed to the Company's Board of Directors in the newly created position of Executive Chairman on January 19, 2009, and on February 10, 2009, was appointed to serve as interim Chief Executive Officer. He resigned from the interim Chief Executive Officer position on March 24, 2010, upon the hiring of Stephen T. Lundy, and resigned from the Chairman position in October 2010. He continued to serve as a Director and was a member of the Audit Committee and chair of the Nominating and Corporate Governance Committee. The source carries no additional biographical information regarding prior employment, education, or other board positions.

Biography extracted from Riot DEF 14A filed 2016-10-17 View cached copy (2026-09-27)Live source ↗

Roles

Contiguous filings for the same role are collapsed into a single tenure span. Click a row to see the underlying filings.

Compensation

As reported in the company's DEF 14A Summary Compensation Table (SEC Reg S-K Item 402(c)). Stock and option awards are grant-date fair values — what the award was worth on the day it was granted, not cash received and not what it is worth now. Every row here reconciles: its columns add up to the total the filing printed.

Insider transactions

Totals for this person

Invested = shares acquired (buys, grants, option exercises) — insider adding to the position. Divested = shares reduced (sells, dispositions, tax-withholding) — cash flowing TO the insider. Net direction shows which side wins on dollar terms in each bucket. % of holder's stake not yet computed (pending Form 3/4 holdings ingest). See methodology. The two @ last price columns restate the same share counts at the most recent share price we read (close of 2026-10-30); they are a valuation, not a cash flow, and they move every day the market does.

All transactions